The effectiveness unlocks a large block of shares for secondary selling, creating near-term overhang. Monitor for any selling stockholder filings (Form 144) or volume spikes in the coming days. The company's cash position was recently boosted by the $80M private placement, so no immediate capital need — but the overhang may cap upside until the registered shares are absorbed.
Price Chart
Executive Summary
First Tracks Biotherapeutics' S-1 registration (333-295719) became effective on May 12, 2026, covering the resale of up to 10,497,054 shares by selling stockholders. The company receives no proceeds from this offering, which stems from a March 2026 private placement that raised ~$80M at $13.81/share. The effectiveness creates a near-term overhang as the registered shares become freely tradable, though the company itself is not raising capital.
Key Facts
- S-1 registration effective May 12, 2026 (SEC File No. 333-295719)
- Covers resale of up to 10,497,054 shares by selling stockholders
- Company receives no proceeds from this offering
- Shares stem from March 2026 private placement at $13.81/share raising ~$80M for the company
- Effectiveness date: May 12, 2026; filing accepted May 13, 2026
Financial Impact
Up to 10.5M shares become eligible for resale, representing ~16.9% of current shares outstanding (based on ~62M shares at $621M market cap / ~$10 stock price). No new capital raised by the company.
Risk Factors
- Near-term selling pressure from registered shares entering the market
- Potential price suppression until the overhang clears
- No company proceeds from this offering — dilution without capital benefit
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-001596 |
| Document: 9999999995-26-001596-index.html | 9999999995-26-001596 |
| Document: 9999999995-26-001596.txt | 9999999995-26-001596 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | S-1 | $43.80 | awaiting T+1 | — | $44.05 (+0.57%) |
Oct 20, 2026 5d ago | 8-K | $42.77 $43.14 | ▲ +0.87% | ▲ +2.05% | $44.05 (+2.99%) |
Oct 15, 2026 10d ago | 8-K | $34.46 $36.28 | ▼ −5.28% | ▼ −4.86% | $44.05 (−27.83%) |
Oct 15, 2026 11d ago | Press Release | $36.04 $34.46 | ▲ +4.38% | ▲ +3.28% | $44.05 (−22.23%) |
Oct 13, 2026 13d ago | 8-K | $31.68 $34.13 | ▲ +7.73% | ▲ +8.81% | $44.05 (+39.05%) |
Aug 12, 2026 10w ago | 8-K | $44.03 $44.04 | ▲ +0.02% | ▲ +0.22% | $44.05 (+0.05%) |
Aug 12, 2026 10w ago | Press Release | $44.03 $44.04 | ▲ +0.02% | ▲ +0.22% | $44.05 (+0.05%) |
Aug 7, 2026 11w ago | 3/A | $47.92 $46.75 | ▼ −2.44% | ▼ −2.12% | $44.05 (−8.08%) |
Jun 22, 2026 17w ago | 8-K | $17.78 $16.69 | ▼ −6.13% | ▼ −6.08% | $44.05 (+147.75%) |
May 14, 2026 23w ago | 8-K | $16.90 $17.79 | ▲ +5.27% | ▲ +5.33% | $44.05 (+160.65%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers